SCHEMBL1639

SCHEMBL1639

COC(=O)[C@H](Cc1ccc(F)cc1)NCc1ccc(-c2ccccc2C(=O)OC(C)[Si](C)(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
CA12 O43570 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
BDKRB1 P46663 4/20 0.40
ITGB1 P05556 3/20 0.40
ITGA4 P13612 3/20 0.40
ITGB7 P26010 3/20 0.40
NOS2 P35228 3/20 0.39
NOS3 P29474 2/20 0.39
NOS1 P29475 2/20 0.39
PDCD1 Q15116 2/20 0.39
CD274 Q9NZQ7 2/20 0.39
SCN1A P35498 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
TSHR P16473 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3035 0.87 SLC6A4 (0.47) SLC6A4SLC6A3BDKRB1PDCD1CD274
SCHEMBL3019 0.80 ADRB3 (0.42) BDKRB1PDCD1CD274SCN1ASCN2A
SCHEMBL2065 0.77 CA12 (0.50) CA12CA7CA9CA14ITGB1
SCHEMBL2746 0.77 AGTR1 (0.53) SLC6A4SLC6A3
SCHEMBL2126 0.76 SCN1A (0.48) SLC6A4SLC6A3BDKRB1SCN1ASCN2A
SCHEMBL3201 0.74 SCN1A (0.49) SLC6A4SLC6A3BDKRB1SCN1ASCN2A
SCHEMBL3036 0.73 SLC6A4 (0.46) SLC6A4SLC6A3CA12CA7CA9
SCHEMBL2970 0.72 BDKRB1 (0.39) BDKRB1PDCD1CD274SCN1ASCN2A
SCHEMBL2721 0.72 BDKRB1 (0.39) BDKRB1PDCD1CD274SCN1ASCN2A
SCHEMBL2301 0.71 SCN1A (0.47) SLC6A4SLC6A3SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965592-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1999-10-12 US disclosed
EP-0443983-B1 Acyl compounds CIBA GEIGY AG (CH) 1996-02-28 EP disclosed
US-5399578-A Hypotensive; valsartan; high blood pressure and cardiac insufficiency CIBA-GEIGY CORP (US) 1995-03-21 US disclosed
EP-0443983-A1 Acyl compounds CIBA-GEIGY AG (CH) 1991-08-28 EP disclosed